Antibiotics to be reclassified for resistance preventing sake

Published: 2000-11-27 10:34:00

Updated: 2000-11-27 10:34:00

Mr. Kim Young-chan, the 4th grade KFDA official, said in the conference of the Korea Society of Infections held at Catholic Medical School on Nov. 24 that antibiotics should be reclassified in order to protect patients from its resistance and complicated infection problems and to encourage correc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK